DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $52,373 | +60.1% | 2,255,470 | +41.5% | 0.01% | +50.0% |
Q1 2024 | $32,716 | -40.8% | 1,594,333 | -38.1% | 0.00% | -42.9% |
Q4 2023 | $55,245 | -7.4% | 2,574,321 | -11.0% | 0.01% | -22.2% |
Q3 2023 | $59,662 | -41.3% | 2,891,950 | -16.1% | 0.01% | -35.7% |
Q2 2023 | $101,672 | +24.7% | 3,445,312 | -2.6% | 0.01% | +16.7% |
Q1 2023 | $81,511 | -19.7% | 3,537,778 | -3.0% | 0.01% | -25.0% |
Q4 2022 | $101,475 | -99.9% | 3,648,888 | +4.9% | 0.02% | -5.9% |
Q3 2022 | $106,752,000 | -21.3% | 3,478,368 | -24.6% | 0.02% | 0.0% |
Q2 2022 | $135,678,000 | -14.3% | 4,610,177 | -6.4% | 0.02% | +6.2% |
Q1 2022 | $158,387,000 | -23.4% | 4,923,425 | +6.2% | 0.02% | -15.8% |
Q4 2021 | $206,740,000 | -13.9% | 4,635,433 | -2.6% | 0.02% | -17.4% |
Q3 2021 | $240,039,000 | -37.6% | 4,757,965 | -3.0% | 0.02% | -36.1% |
Q2 2021 | $384,627,000 | +11.2% | 4,903,452 | -19.1% | 0.04% | +2.9% |
Q1 2021 | $345,928,000 | -36.1% | 6,058,279 | -6.3% | 0.04% | -37.5% |
Q4 2020 | $541,494,000 | +246.5% | 6,464,826 | +48.2% | 0.06% | +211.1% |
Q3 2020 | $156,254,000 | +146.4% | 4,360,975 | +66.3% | 0.02% | +125.0% |
Q2 2020 | $63,404,000 | +199.0% | 2,622,162 | +116.5% | 0.01% | +166.7% |
Q1 2020 | $21,205,000 | +191.8% | 1,211,039 | +190.3% | 0.00% | +200.0% |
Q4 2019 | $7,267,000 | +7.8% | 417,156 | -5.2% | 0.00% | 0.0% |
Q3 2019 | $6,744,000 | -32.5% | 440,197 | -8.5% | 0.00% | 0.0% |
Q2 2019 | $9,988,000 | -10.6% | 481,140 | -0.0% | 0.00% | -50.0% |
Q1 2019 | $11,177,000 | +13.4% | 481,342 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $9,860,000 | -4.7% | 477,242 | +0.2% | 0.00% | 0.0% |
Q3 2018 | $10,350,000 | +86.6% | 476,067 | +30.9% | 0.00% | +100.0% |
Q2 2018 | $5,548,000 | -24.2% | 363,825 | -2.1% | 0.00% | 0.0% |
Q1 2018 | $7,321,000 | – | 371,806 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |